Related Experiment Video

Updated: Sep 30, 2026

Intracameral Injection in Rats with Low Risk of Adverse Effects
06:19

Intracameral Injection in Rats with Low Risk of Adverse Effects

Published on: May 31, 2024

[Fungal infections of the eye--current antifungal agents]

Agnieszka Samsel1, Jadwiga Meszaros

  • 1Katedry i Kliniki Chorób Oczu Akademii Medycznej, Warszawie.

Klinika Oczna
|August 15, 2002
PubMed

Insights

This review covers antifungal agents for ocular infections, detailing common causes, mechanisms, and available treatments. It also highlights emerging antifungal drugs currently in clinical trials for eye infections.

Area of Science:

  • Ophthalmology
  • Mycology
  • Pharmacology

Context:

  • Fungal infections of the eye (ocular mycoses) represent a significant cause of visual impairment and blindness globally.
  • Accurate diagnosis and timely treatment are crucial to prevent irreversible vision loss.

Purpose:

  • To provide a comprehensive overview of antifungal agents used in treating ocular infections.
  • To describe the common etiologies of fungal eye infections.
  • To review the mechanisms of action, spectrum of activity, and current therapeutic options, including agents in clinical development.

Summary:

  • The review details the most frequent causes of fungal keratitis and endophthalmitis.
  • It discusses established antifungal drugs, their pharmacodynamics, and clinical applications in ophthalmology.
  • Emerging antifungal agents undergoing clinical trials are also presented, offering insights into future treatment strategies.

Impact:

  • This information aids ophthalmologists and infectious disease specialists in selecting appropriate antifungal therapies for ocular mycoses.
  • Understanding new treatment modalities can improve patient outcomes and reduce the burden of fungal eye infections.
  • Facilitates informed decision-making in managing complex and sight-threatening ocular fungal diseases.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Microbiome of the Eye01:22

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...